Sigachi Industries Quarterly Results for Trading Insights

SIGACHI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹11 Cr
QSept 2025
Quarterly Results

Sigachi Industries Quarterly Results Key Highlights

  • Revenue of ₹118 Cr in Sept 2025 (-9.2% vs Mar 2025, -15.7% vs Sept 2024)
  • Net Profit of ₹11 Cr in Sept 2025 (-31.2% vs Mar 2025, -47.6% vs Sept 2024)
  • EBITDA of ₹15 Cr in Sept 2025 (-51.6% vs Mar 2025)
  • Operating Margin of 7.0% in Sept 2025 (-15.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.28 in Sept 2025 (-22.2% vs Mar 2025)

Sigachi Industries Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 118 130 132 118 140 -9.2% -15.7%
Net Profit (₹ Cr) 11 16 -101 0 21 - -
EBITDA (₹ Cr) 15 31 -93 6 32 - -
EPS (₹) 0.28 0.36 -2.63 0.01 0.66 - -
Operating Margin (%) 7.0% 22.0% -76.0% 4.0% 14.0% - -

Sigachi Industries Share Price Trend Around Quarterly Results

Visualize Sigachi Industries's 1-year price movement across quarterly results — ideal for logging trades in Sigachi Industries share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 9.3%
EBITDA Margin 12.7%
Operating Margin 7.0%
ROE (Annual) 7.2%

Balance Sheet Highlights

Total Assets ₹846 Cr
Total Equity ₹613 Cr
Current Assets ₹394 Cr
Current Liabilities ₹48 Cr

Cash Flow Analysis

Operating Cash Flow ₹27 Cr
Investing Cash Flow ₹-93 Cr
Financing Cash Flow ₹81 Cr
Net Cash Flow ₹15 Cr

Current Market Data

Current Price ₹19.82
Exchange NSE
Last Updated Mar 02, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Sigachi Industries quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹416,764.48 Cr 1752.5 14,875 3,125 +10.8% - 21.0% 134.8
Divis Laboratories
Sept 2025
₹170,125.54 Cr 6403.5 2,860 689 +7.1% - 24.1% 246.6
Torrent Pharmaceuti…
Sept 2025
₹146,658.56 Cr 4369.2 3,219 591 +11.3% - 18.4% 249.1
Cipla
Sept 2025
₹109,178.44 Cr 1351.6 7,716 1,353 +12.0% - 17.5% 80.8
Dr Reddys Laborator…
Sept 2025
₹107,358.50 Cr 1294.4 9,135 1,337 +1.1% - 14.6% 80.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores